
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
The Entre system is a straightforward lymphedema pump that uses basic pneumatic compression to help patients manage their chronic swelling and venous ulcers at home. These conditions are brought on by lymphedema and chronic venous insufficiency (CVI).
In a boot or sleeve that inflates and deflates at regular intervals, they gently "squeeze" a swollen leg. Lymphoedema can quickly subside in an arm or leg, but the lymph fluid may build up in the body's trunk and cause discomfort. In addition, removing the pump could cause the limb to swell swiftly once more.
The Global Lymphedema Pump Market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
Dayspring Lower Extremity Active Compression Treatments for Lymphedema and Venous Disorders were launched by Koya Medical. The U.S. Food and Drug Administration has approved Dayspring as the first active dynamic compression treatment that is not pneumatic (FDA).
It is wearable and specifically made for patient mobility. In contrast to existing pneumatic (air-based) compression pumps, which demand that patients remain immobile and that the devices be connected into an outlet, Dayspring provides necessary body movement and mobility so that patients can resume their everyday activities while receiving therapy.
Dayspring's treatment for the upper extremities has been commercially available and the company's development into lower extremity care, which is offered in both full and lower leg applications, will enable it to better assist those who have lymphedema and venous disorders.In order to effectively manage lymphedema, venous insufficiency, and other chronic edemas, daily vital activity aids in the promotion of healthy lymph fluid flow.
Dayspring active compression was created with the goal of assisting patients in maintaining their mobility and receiving the necessary care without allowing it to get in the way.
They look forward to offering persons with lymphedema and venous insufficiency in their lower limbs at-home active compression therapy alternatives that permit normal leg movements to aid in reducing swelling and maintaining limb volume. Securing codes from CMS is a crucial step in developing novel treatment choices for patients with lymphedema, as well as their caregivers and medical professionals.
Sl no | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Abbreviations |
4 | Research Methodology |
5 | Executive Summary |
6 | Introduction |
7 | Insights from Industry stakeholders |
8 | Cost breakdown of Product by sub-components and average profit margin |
9 | Disruptive innovation in the Industry |
10 | Technology trends in the Industry |
11 | Consumer trends in the industry |
12 | Recent Production Milestones |
13 | Component Manufacturing in US, EU and China |
14 | COVID-19 impact on overall market |
15 | COVID-19 impact on Production of components |
16 | COVID-19 impact on Point of sale |
17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
21 | Product installation rate by OEM, 2023 |
22 | Incline/Decline in Average B-2-B selling price in past 5 years |
23 | Competition from substitute products |
24 | Gross margin and average profitability of suppliers |
25 | New product development in past 12 months |
26 | M&A in past 12 months |
27 | Growth strategy of leading players |
28 | Market share of vendors, 2023 |
29 | Company Profiles |
30 | Unmet needs and opportunity for new suppliers |
31 | Conclusion |
32 | Appendix |